Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Ocular Graft-Versus-Host Disease
Ocular GVHD (oGVHD), manifested by severe injury of corneal epithelial cells, meibomian and lacrimal glands’ dysfunction, is a serious complication of systemic GVHD which develops as a consequence of donor T and natural killer cell-driven inflammation in the eyes of patients who received allogeneic...
Main Authors: | Carl Randall Harrell, Valentin Djonov, Vladislav Volarevic |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/21/13254 |
Similar Items
-
Ocular graft-versus-host disease: An update on immune pathogenesis and therapies
by: Samantha P. Peña-Lozano, et al.
Published: (2022-07-01) -
Current status of research and treatment of dry eye associated with chronic ocular graft-versus-host disease
by: Yuan Liang, et al.
Published: (2022-12-01) -
Mesenchymal Stem Cell-Derived Exosomes as New Remedy for the Treatment of Neurocognitive Disorders
by: Carl Randall Harrell, et al.
Published: (2021-02-01) -
Therapeutic Use of Mesenchymal Stem Cell-Derived Exosomes: From Basic Science to Clinics
by: Carl Randall Harrell, et al.
Published: (2020-05-01) -
Therapeutic Potential of Exosomes Derived from Adipose Tissue-Sourced Mesenchymal Stem Cells in the Treatment of Neural and Retinal Diseases
by: Carl Randall Harrell, et al.
Published: (2022-04-01)